期刊文献+

瑞舒伐他汀对老年2型糖尿病合并颈动脉斑块患者同型半胱氨酸与高敏C反应蛋白及血脂的影响 被引量:10

Effects of rosuvastatin on blood homocysteine, high sensitivity C reactive protein and blood lipid in elderly patients with type 2 diabetes mellitus complicated with carotid artery plaque
下载PDF
导出
摘要 目的 探讨瑞舒伐他汀对老年2型糖尿病合并颈动脉斑块患者同型半胱氨酸(Hcy)、高敏C反应蛋白(hs-CRP)及血脂的影响.方法 将96例老年2型糖尿病合并颈动脉斑块患者使用随机数字表法分为对照组(46例)和观察组(50例).对照组进行常规治疗,观察组在常规治疗基础上加用瑞舒伐他汀5 mg/d,口服.比较2组患者治疗前和治疗后6周hs-CRP、Hcy、空腹血糖、三酰甘油、总胆固醇、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇水平.结果 治疗后,观察组总胆固醇、LDL-C、hs-CRP、Hcy均明显低于对照组,差异均有统计学意义[总胆固醇:(4.1±l.2)mmol/L比(4.6±0.9) mmol/L,LDL-C:(2.2±0.6) mmol/L比(2.6±0.6) mmol/L,hs-CRP:(12±4)mg/L比(14±4) mg/L,Hcy:(13±4) μmol/L比(15 ±3)μmol/L](均P<0.05).2组患者治疗前后肾功能、尿常规无明显变化.观察组l例患者肝功能受损,未停药,加用益肝灵口服2周后肝功能恢复.结论 瑞舒伐他汀可以降低老年2型糖尿病合并颈动脉斑块患者血脂、Hcv和hs-CRP水平. Objective To investigate the effects of rosuvastatin on blood homocysteine (Hcy),high-sensitivity C reactive protein (hs-CRP) and blood lipid in the elderly patients with type 2 diabetes mellitus complicated with carotid artery plaque.Methods Ninety-six senile patients with type 2 diabetes complicated with carotid artery plaque were randomly divided into control group (46 cases) receiving conventional treatment and observation group (50 cases) taking oral rosuvastatin (5 mg/d) in addition to conventional treatment.Before and 6 weeks after treatment,the levels of Hcy,hs-CRP,blood glucose,triglycerides (TG),total cholesterol (TC),low density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) were measured and compared between the two groups.Results The levels of blood hs-CRP,TG,TC,LDL-C,Hcy in observation group were significantly lower than those in control group [TC:(4.1 ± 1.2) mmol/L vs (4.6 ± 0.9) mmol/L,LDL-C:(2.2±0.6) mmol/L vs (2.6±0.6) mmol/L,hs-CRP:(12±4) mg/L vs (14±4) mg/L,Hcy:(13±4) μmol/L vs (15 ± 3) μmol/L] (P < 0.05).No significant changes of renal function and routine urine test were found after treatment in both the two groups.One case in observation group had impaired fiver function and recovered after taking oral silymarin for two weeks.Conclusion Rosuvastatin can decrease the levels of blood TG,TC,LDL-C,Hcy and hs-CRP in the elderly patients with type 2 diabetes mellitus complicatred with carotid plaque.
出处 《中国医药》 2015年第5期649-651,共3页 China Medicine
关键词 糖尿病 2型 颈动脉斑块 同型半胱氨酸 高敏C反应蛋白 瑞舒伐他汀 Diabetes mellitus, type 2 Carotid artery plaque Homocysteine High-sensitivity C reactive protein Rosuvastatin
  • 相关文献

参考文献15

二级参考文献77

共引文献103

同被引文献116

引证文献10

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部